Literature DB >> 32870135

T1-weighted Dynamic Contrast-enhanced MRI to Differentiate Nonneoplastic and Malignant Vertebral Body Lesions in the Spine.

Youxin Guan1, Kyung K Peck1, John Lyo1, Jamie Tisnado1, Eric Lis1, Julio Arevalo-Perez1, Yoshiya Yamada1, Meera R Hameed1, Sasan Karimi1, Andrei Holodny1.   

Abstract

Background Dynamic contrast agent-enhanced (DCE) perfusion MRI may help differentiate between nonneoplastic and malignant lesions in the spine. Purpose To investigate the correlation between fractional plasma volume (Vp), a parameter derived from DCE perfusion MRI, and histopathologic diagnosis for spinal lesions. Materials and Methods In this retrospective study, patients who underwent DCE perfusion MRI and lesion biopsy between May 2015 and May 2018 were included. Inclusion criteria were short time interval (<30 days) between DCE perfusion MRI and biopsy, DCE perfusion MRI performed before biopsy, and DCE perfusion MRI performed at the same spine level as biopsy. Exclusion criteria were prior radiation treatment on vertebrae of interest, poor DCE perfusion MRI quality, nondiagnostic biopsy, and extensive spinal metastasis or prior kyphoplasty. One hundred thirty-four lesions were separated into a nonneoplastic group (n = 51) and a malignant group (n = 83) on the basis of histopathologic analysis. Two investigators manually defined regions of interest in the vertebrae. DCE perfusion MRI parameter Vp was calculated by using the Tofts pharmacokinetic two-compartment model. Vp was quantified, normalized to adjacent normal vertebrae, and compared between the two groups. A Mann-Whitney U test and receiver operating characteristic analysis was performed to verify the difference in Vp between the nonneoplastic and malignant groups. Reproducibility was assessed by calculating the Cohen κ coefficient. Results One hundred patients (mean age, 65 years ± 11 [standard deviation]; 52 men) were evaluated. Vp was lower in nonneoplastic lesions versus malignant lesions (1.6 ± 1.3 vs 4.2 ± 3.0, respectively; P < .001). The sensitivity of Vp was 93% (77 of 83; 95% confidence interval [CI]: 85%, 97%), specificity was 78% (40 of 51; 95% CI: 65%, 89%), and area under the receiver operating characteristic curve was 0.88 (95% CI: 0.82, 0.95). Cohen κ coefficient suggested substantial agreement in both intra- (κ = 0.72) and interreader (κ = 0.70) reproducibility. Conclusion This study indicated that dynamic contrast agent-enhanced perfusion MRI parameter, fractional plasma volume, was able to differentiate between nonneoplastic spinal lesions and malignant lesions. © RSNA, 2020 Online supplemental material is available for this article. See also the editorial by Haller in this issue.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32870135      PMCID: PMC7643814          DOI: 10.1148/radiol.2020190553

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  19 in total

Review 1.  Mechanisms of bone metastasis.

Authors:  G David Roodman
Journal:  N Engl J Med       Date:  2004-04-15       Impact factor: 91.245

2.  Percutaneous CT-guided biopsy of osseous lesion of the spine in patients with known or suspected malignancy.

Authors:  Eric Lis; Mark H Bilsky; Leszek Pisinski; Patrick Boland; John H Healey; Bernie O'malley; George Krol
Journal:  AJNR Am J Neuroradiol       Date:  2004-10       Impact factor: 3.825

3.  Differentiation of Schmorl Nodes From Bone Metastases of the Spine: Use of Apparent Diffusion Coefficient Derived From DWI and Fat Fraction Derived From a Dixon Sequence.

Authors:  Jin Ho Lee; Sekyoung Park
Journal:  AJR Am J Roentgenol       Date:  2019-08-28       Impact factor: 3.959

4.  Magnetic resonance imaging of the spinal cord and canal: potentials and limitations.

Authors:  D Norman; C M Mills; M Brant-Zawadzki; A Yeates; L E Crooks; L Kaufman
Journal:  AJR Am J Roentgenol       Date:  1983-12       Impact factor: 3.959

Review 5.  Molecular mechanisms and clinical applications of angiogenesis.

Authors:  Peter Carmeliet; Rakesh K Jain
Journal:  Nature       Date:  2011-05-19       Impact factor: 49.962

6.  Global cancer transitions according to the Human Development Index (2008-2030): a population-based study.

Authors:  Freddie Bray; Ahmedin Jemal; Nathan Grey; Jacques Ferlay; David Forman
Journal:  Lancet Oncol       Date:  2012-06-01       Impact factor: 41.316

7.  Differentiating benign from malignant vertebral fractures using T1 -weighted dynamic contrast-enhanced MRI.

Authors:  Julio Arevalo-Perez; Kyung K Peck; John K Lyo; Andrei I Holodny; Eric Lis; Sasan Karimi
Journal:  J Magn Reson Imaging       Date:  2015-02-05       Impact factor: 4.813

Review 8.  Palliative radiotherapy trials for bone metastases: a systematic review.

Authors:  Edward Chow; Kristin Harris; Grace Fan; May Tsao; Wai M Sze
Journal:  J Clin Oncol       Date:  2007-04-10       Impact factor: 44.544

9.  A Pilot Study Evaluating the Use of Dynamic Contrast-Enhanced Perfusion MRI to Predict Local Recurrence After Radiosurgery on Spinal Metastases.

Authors:  Kiran A Kumar; Kyung K Peck; Sasan Karimi; Eric Lis; Andrei I Holodny; Mark H Bilsky; Yoshiya Yamada
Journal:  Technol Cancer Res Treat       Date:  2017-04-28

10.  Application of monoexponential, biexponential, and stretched-exponential models of diffusion-weighted magnetic resonance imaging in the differential diagnosis of metastases and myeloma in the spine-Univariate and multivariate analysis of related parameters.

Authors:  Xiaoying Xing; Jiahui Zhang; Yongye Chen; Qiang Zhao; Ning Lang; Huishu Yuan
Journal:  Br J Radiol       Date:  2020-06-11       Impact factor: 3.039

View more
  1 in total

1.  Differentiation of Skull Base Chondrosarcomas, Chordomas, and Metastases: Utility of DWI and Dynamic Contrast-Enhanced Perfusion MR Imaging.

Authors:  Y Ota; E Liao; A A Capizzano; A Baba; R Kurokawa; M Kurokawa; A Srinivasan
Journal:  AJNR Am J Neuroradiol       Date:  2022-08-11       Impact factor: 4.966

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.